Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$1.05B |
| 2 |
Newmont
NEM
|
$444M |
| 3 |
Moody's
MCO
|
$352M |
| 4 |
Uber
UBER
|
$310M |
| 5 |
Veralto
VLTO
|
$276M |
Top Sells
| 1 |
Apple
AAPL
|
$1.02B |
| 2 |
Microsoft
MSFT
|
$926M |
| 3 |
HES
Hess
HES
|
$521M |
| 4 |
Merck
MRK
|
$454M |
| 5 |
ATVI
Activision Blizzard Inc.
ATVI
|
$438M |
Sector Composition
| 1 | Technology | 26.34% |
| 2 | Healthcare | 12.26% |
| 3 | Financials | 11.94% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3826
OP Bancorp
OPBK
$212M
| $196K | ﹤0.01% |
17,913
-40,220
| -69% | -$440K |
|
3827
National CineMedia
NCMI
$411M
| $195K | ﹤0.01% |
47,175
| – | – |
|
|
NBH
3828
Neuberger Berman Municipal Fund
NBH
$299M
| $195K | ﹤0.01% |
+18,818
| New | +$195K |
|
3829
Esperion Therapeutics
ESPR
$540M
| $195K | ﹤0.01% |
65,134
+37,738
| +138% | +$113K |
|
3830
Co-Diagnostics
CODX
$11.9M
| $194K | ﹤0.01% |
145,621
| – | – |
|
3831
Zura Bio
ZURA
$143M
| $193K | ﹤0.01% |
41,407
+7,434
| +22% | +$34.7K |
|
3832
Zedge
ZDGE
$41.4M
| $193K | ﹤0.01% |
81,934
| – | – |
|
3833
ProPhase Labs
PRPH
$14.7M
| $192K | ﹤0.01% |
42,531
-20,865
| -33% | -$94.3K |
|
3834
NL Industries
NL
$311M
| $192K | ﹤0.01% |
34,167
-140,647
| -80% | -$789K |
|
3835
Lexeo Therapeutics
LXEO
$271M
| $189K | ﹤0.01% |
+14,110
| New | +$189K |
|
3836
Adicet Bio
ACET
$60M
| $184K | ﹤0.01% |
97,539
-33,854
| -26% | -$64K |
|
|
AKTS
3837
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $184K | ﹤0.01% |
220,393
| – | – |
|
3838
Blend Labs
BLND
$1.05B
| $182K | ﹤0.01% |
71,423
+894
| +1% | +$2.28K |
|
3839
Nuveen Municipal Value Fund
NUV
$1.82B
| $182K | ﹤0.01% |
21,128
-30,252
| -59% | -$260K |
|
3840
OPAL Fuels
OPAL
$65.5M
| $181K | ﹤0.01% |
32,753
+17,516
| +115% | +$96.7K |
|
3841
MediciNova
MNOV
$63.3M
| $180K | ﹤0.01% |
119,894
-99
| -0.1% | -$149 |
|
3842
Trevi Therapeutics
TRVI
$854M
| $179K | ﹤0.01% |
133,381
-699
| -0.5% | -$937 |
|
3843
Veritone
VERI
$147M
| $179K | ﹤0.01% |
98,739
-129,526
| -57% | -$234K |
|
3844
SWK Holdings
SWKH
$178M
| $177K | ﹤0.01% |
12,731
-177
| -1% | -$2.46K |
|
3845
5E Advanced Materials
FEAM
$77.2M
| $173K | ﹤0.01% |
5,344
-675
| -11% | -$21.9K |
|
3846
Champions Oncology
CSBR
$94.3M
| $173K | ﹤0.01% |
30,775
| – | – |
|
3847
Vermilion Energy
VET
$1.12B
| $173K | ﹤0.01% |
14,318
-50,114
| -78% | -$604K |
|
3848
Neuronetics
STIM
$214M
| $172K | ﹤0.01% |
59,246
-793
| -1% | -$2.3K |
|
3849
Outlook Therapeutics
OTLK
$41.5M
| $171K | ﹤0.01% |
21,728
| – | – |
|
|
FMN
3850
Federated Hermes Premier Municipal Income Fund
FMN
$84.1M
| $170K | ﹤0.01% |
15,485
-24
| -0.2% | -$264 |
|